Tobacco Mosaic Viral Nanoparticle Inhibited Osteoclastogenesis Through Inhibiting mTOR/AKT Signaling

Zhongshu Shan1,2, Hongtao Bi3, Angxiu Suonan2

  • 1Department of Orthopedic Surgery, The 1st Affiliated Hospital of Soochow University, Suzhou, Jiangsu, People's Republic of China.

Abstract

Insights

Tobacco mosaic virus nanoparticles (TMV VNPs) inhibit osteoclast formation and enhance bone healing. TMV-RGD1 modified nanoparticles show superior efficacy in promoting bone repair and reducing osteoclasts.

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Regenerative Medicine

Background:

  • Tobacco mosaic virus-based nanoparticles (TMV VNPs) promote osteogenic differentiation.
  • Investigating TMV VNPs' effects on osteoclastogenesis and bone healing is crucial.

Purpose of the Study:

  • To evaluate the impact of TMV VNPs on osteoclastogenesis in vitro.
  • To assess TMV VNPs' efficacy in promoting bone injury healing in vivo.

Main Methods:

  • Osteoclast differentiation assays using Raw264.7 cells treated with TMV and TMV-RGD1 VNPs.
  • In vivo study using TMV-RGD1-modified hyaluronic acid hydrogel for mouse tibial bone injury.
  • Analysis included TRAP staining, gene expression, Western blotting, immunofluorescence, micro-CT, and Masson staining.

Main Results:

  • TMV and TMV-RGD1 VNPs significantly inhibited osteoclast differentiation and downregulated key osteoclastogenic markers.
  • TMV VNPs suppressed NF-κB and mTOR/AKT signaling pathways.
  • TMV-RGD1 modified hydrogel significantly promoted bone healing and increased bone mass in vivo, with reduced osteoclast numbers.

Conclusions:

  • TMV VNPs demonstrate significant potential as biomaterials for bone injury repair.
  • TMV-RGD1 modification enhances the efficacy of TMV VNPs in bone regeneration.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.9K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
9.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.4K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.5K